AMNEAL PHARMACEUTICALS, INC. (AMRX) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | Payments of Dividends |
| Net income · 12 months | 157.36M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | (m) | $157.36M | (m) |
| 2026-03-31 | (m) | $122.12M | (m) |
| 2025-12-31 | (m) | $72.06M | (m) |
| 2025-09-30 | (m) | (m) | (m) |
| 2025-06-30 | (m) | (m) | (m) |
| 2025-03-31 | (m) | (m) | (m) |
| 2024-12-31 | (m) | $-116.89M | (m) |
| 2024-09-30 | (m) | $-179.73M | (m) |
| 2024-06-30 | (m) | $-169.89M | (m) |
| 2024-03-31 | (m) | $-163.97M | (m) |
| 2023-12-31 | (m) | $-79.27M | (m) |
| 2023-09-30 | (m) | $10.12M | (m) |
| 2023-06-30 | (m) | $-13.04M | (m) |
| 2023-03-31 | (m) | $-277.40M | (m) |
| 2022-12-31 | (m) | $-270.58M | (m) |
| 2022-09-30 | (m) | $-280.35M | (m) |
| 2022-06-30 | (m) | $-280.52M | (m) |
| 2022-03-31 | (m) | $-8.40M | (m) |
| 2021-12-31 | (m) | $13.16M | (m) |
| 2021-09-30 | (m) | $51.39M | (m) |
| 2021-06-30 | (m) | $37.54M | (m) |
| 2021-03-31 | (m) | $-16.62M | (m) |
| 2020-12-31 | $0.00 | $91.06M | 0.00% |
| 2020-09-30 | (m) | $61.97M | (m) |
| 2020-06-30 | (m) | $-194.06M | (m) |
| 2020-03-31 | (m) | $-198.97M | (m) |
| 2019-12-31 | $0.00 | $-361.92M | 0.00% |
| 2019-09-30 | $0.00 | $-338.56M | 0.00% |
| 2019-06-30 | $0.00 | $-66.66M | 0.00% |
| 2019-03-31 | $153.00M | (m) | (m) |
| 2018-12-31 | $183.00M | $-19.74M | -926.85% |
| 2018-09-30 | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) |
| 2017-12-31 | (m) | (m) | (m) |
| 2017-09-30 | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) |
| 2016-12-31 | $200.62M | $0.00 | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |